title: Alpha-synuclein pathology is highly dependent on the case selection.
abstract: Lewy bodies and dystrophic neurites have been considered a common substrate for dementia, but they are also frequently found in the normal elderly population. The primary component of this pathology involves alpha-synuclein. The main objective of the present study was to estimate the prevalence of alpha-synuclein pathology in aged population, and to assess its relative significance in relation to dementia. The study also investigated whether differences could be detected in alpha-synuclein pathology in relation to age, gender or concomitant Alzheimer's pathology. Furthermore, the influence of sampling strategies was analysed. Alpha-synuclein pathology was assessed using immunohistochemistry in well-characterized post-mortem material. The investigation included patients from a longitudinal study of dementia of Alzheimer's type (n = 103, 85% demented), subjects from a prospective longitudinal clinical study of ageing (n = 69, 29% demented), a cohort of consecutive clinical post-mortem cases collected for 1 year (n = 262, 12% demented), a sample of forensic post-mortem cases collected for 6 months (n = 121, 15% demented) and a sample of Brain Bank material (n = 234, 26% demented). Overall, alpha-synuclein pathology was found in 14% of all 774 subjects over 40 years of age, and this percentage varied from 8% to 27% according to sampling strategies. These results indicate that the prevalence of alpha-synuclein pathology clearly depends on the selection of material. Furthermore alpha-synuclein pathology was found in 23% of clinically demented patients and in 11% of non-demented subjects. The load of alpha-synuclein pathology was significantly greater in the demented patients versus non-demented subjects indicating that alpha-synuclein pathology is indeed of importance in the pathogenesis of dementia.
authors.affiliation: Department of Neuroscience and Neurology, Kuopio University, Kuopio, Finland. Laura.Parkkinen@uku.fi
authors.forename: L
authors.initials: L
authors.lastname: Parkkinen
authors.forename: H
authors.initials: H
authors.lastname: Soininen
authors.forename: M
authors.initials: M
authors.lastname: Laakso
authors.forename: I
authors.initials: I
authors.lastname: Alafuzoff
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000473:pathology*; D000544:Alzheimer Disease / Q000453:epidemiology / Q000473:pathology*; D001921:Brain / Q000473:pathology*; D001923:Brain Chemistry; D005260:Female; D005554:Forensic Medicine; D006801:Humans; D016631:Lewy Bodies / Q000473:pathology; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000032:analysis*; D011237:Predictive Value of Tests; D015995:Prevalence; D011446:Prospective Studies; D051843:Synucleins; D014015:Tissue Banks; D051844:alpha-Synuclein
chemical_list: D009419:Nerve Tissue Proteins; C497604:SNCA protein, human; D051843:Synucleins; D051844:alpha-Synuclein